Tesis Labs is a targeted genetic sequencing company based in Phoenix, AZ that provides genetic testing and precision medicine services to healthcare providers and physicians. The company offers tools to create personalized care plans for treating chronic diseases such as heart disease, lung disease, and cancer, including across generations. Tesis Labs also supports medical device companies and pharmaceutical firms in bringing new products to market and building a repository of genetic data and research. The company’s proprietary products are currently undergoing clinical validation. Management plans to use the new funds to increase production capability, expand clinical support, and advance several clinical initiatives. Ron King is listed as CEO and Managing Director.

Total raised

$20M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2021